Literature DB >> 22388024

Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?

Michael Camilleri.   

Abstract

Ohman et al. report increased fecal granins in patients with irritable bowel syndrome (IBS). Several interesting questions arise from their observations. Are the granins a cause of the pathophysiology or phenotype in IBS? Is the elevation of granins specific to IBS? What is the cause of increased fecal granin levels? Can fecal granin levels be used to diagnose IBS? Are increased fecal granins an expression of intestinal or colonic irritation? This paper adds to the body of evidence suggesting there are gastrointestinal disturbances in IBS; understanding these disturbances may provide clues to its pathogenesis and optimize management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388024      PMCID: PMC3912945          DOI: 10.1038/ajg.2011.465

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  33 in total

Review 1.  Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

2.  Role of fructose-sorbitol malabsorption in the irritable bowel syndrome.

Authors:  G F Nelis; M A Vermeeren; W Jansen
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

3.  Gastrointestinal endocrine cell hyperplasia in celiac disease: a selective proliferative process of serotonergic cells.

Authors:  T N Moyana; S Shukoor
Journal:  Mod Pathol       Date:  1991-07       Impact factor: 7.842

4.  Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin.

Authors:  A T Peregrin; H Ahlman; M Jodal; O Lundgren
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.

Authors:  Shin-ichiro Karaki; Retsu Mitsui; Hisayoshi Hayashi; Ikuo Kato; Hiroshi Sugiya; Toshihiko Iwanaga; John B Furness; Atsukazu Kuwahara
Journal:  Cell Tissue Res       Date:  2006-02-01       Impact factor: 5.249

6.  Neural and non-neural mediation of propionate-induced contractile responses in the rat distal colon.

Authors:  R Mitsui; S Ono; S Karaki; A Kuwahara
Journal:  Neurogastroenterol Motil       Date:  2005-08       Impact factor: 3.598

7.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

Review 8.  Chromogranin A.

Authors:  G N Hendy; S Bevan; M G Mattei; A J Mouland
Journal:  Clin Invest Med       Date:  1995-02       Impact factor: 0.825

9.  Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.

Authors:  Ulrich Wahnschaffe; Jörg-Dieter Schulzke; Martin Zeitz; Reiner Ullrich
Journal:  Clin Gastroenterol Hepatol       Date:  2007-06-05       Impact factor: 11.382

10.  Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants.

Authors:  Mark Kidd; Irvin M Modlin; Bjorn I Gustafsson; Ignat Drozdov; Oyvind Hauso; Roswitha Pfragner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-12       Impact factor: 4.052

View more
  7 in total

Review 1.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 2.  Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.

Authors:  Dervla O'Malley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-13       Impact factor: 4.052

Review 3.  Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea.

Authors:  Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

Review 4.  Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.

Authors:  Jan Däbritz; Jason Musci; Dirk Foell
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 5.  Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers.

Authors:  Ivana Plavšić; Goran Hauser; Mladenka Tkalčić; Sanda Pletikosić; Nermin Salkić
Journal:  Gastroenterol Res Pract       Date:  2015-06-11       Impact factor: 2.260

6.  The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response.

Authors:  Rebeca Martín; Celia Chamignon; Nadia Mhedbi-Hajri; Florian Chain; Muriel Derrien; Unai Escribano-Vázquez; Peggy Garault; Aurélie Cotillard; Hang Phuong Pham; Christian Chervaux; Luis G Bermúdez-Humarán; Tamara Smokvina; Philippe Langella
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

7.  Preterm Delivery: Microbial Dysbiosis, Gut Inflammation and Hyperpermeability.

Authors:  Silvia Arboleya; David Rios-Covian; Flore Maillard; Philippe Langella; Miguel Gueimonde; Rebeca Martín
Journal:  Front Microbiol       Date:  2022-02-04       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.